☆ 4.7 Letter

What Is the Optimal Model to Estimate the Benefits of Chemotherapy in Patients With Hormone Receptor-Positive, HER2-Negative, NodeNegative Breast Cancer? Reply

JOURNAL OF CLINICAL ONCOLOGY (2021)

Get Full Text
Add to Collection

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 39, Issue 17, Pages 1947-+

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/JCO.21.00424

Keywords

-

Categories

Oncology

Funding

  1. NCI NIH HHS [UG1 CA189859] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.